Case No. | Gender | Lymphadenopathy | WBC | ALT | AST | CK | ALP | LDH | Days after onset(AP) | IgM(AP) | IgG(AP) | Days after onset(CP) | IgM(CP) | IgG(CP) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | N | L | H | H | N | N | H | 35 | > 10 | 100 | 320 | < 10 | 1600 |
2 | F | N | N | H | H | H | N | H | 3 | < 10 | 100 | 290 | < 10 | 100 |
3 | F | N | L | N | N | – | N | H | 5 | < 10 | < 100 | 282 | < 10 | < 100 |
4 | F | N | L | H | N | N | N | N | 5 | < 10 | < 100 | 313 | < 10 | < 100 |
5 | M | N | L | H | H | H | N | H | 1 | > 10 | < 100 | 386 | < 10 | 400 |
6 | M | N | N | H | H | H | H | H | 13 | > 10 | < 100 | 407 | > 10 | 1600 |
7 | M | N | N | H | H | H | N | H | 17 | > 10 | < 100 | 410 | > 10 | 400 |
8 | F | Y | L | N | H | N | N | N | 4 | < 10 | < 100 | 373 | < 10 | 100 |
9 | M | N | L | H | H | H | L | H | 9 | > 10 | < 100 | 423 | < 10 | 400 |
10 | F | Y | L | H | H | H | N | H | 9 | > 10 | < 100 | 470 | < 10 | 400 |
11 | M | N | L | H | H | H | N | H | 12 | > 10 | < 100 | 473 | < 10 | 100 |
12 | F | N | L | H | H | H | N | H | 12 | > 10 | 100 | 478 | < 10 | 400 |
13 | M | N | L | H | H | H | N | H | 15 | > 10 | < 100 | 482 | > 10 | 400 |
14 | M | N | N | N | N | N | N | N | 5 | < 10 | < 100 | 551 | < 10 | < 100 |